IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $244 | -100.0% | 5,956 | -79.8% | 0.00% | -87.5% |
| Q2 2022 | $1,091,000 | +4.7% | 29,479 | +4.8% | 0.01% | +14.3% |
| Q1 2022 | $1,042,000 | +35.9% | 28,122 | +11.5% | 0.01% | +16.7% |
| Q4 2021 | $767,000 | -7.1% | 25,217 | +2.4% | 0.01% | -14.3% |
| Q3 2021 | $826,000 | -9.1% | 24,614 | +8.0% | 0.01% | -12.5% |
| Q2 2021 | $909,000 | +1.6% | 22,786 | +14.5% | 0.01% | -11.1% |
| Q1 2021 | $895,000 | +343.1% | 19,896 | +495.0% | 0.01% | +200.0% |
| Q4 2019 | $202,000 | -1.5% | 3,344 | -2.5% | 0.00% | 0.0% |
| Q3 2019 | $205,000 | -22.9% | 3,430 | -17.0% | 0.00% | -25.0% |
| Q2 2019 | $266,000 | +6.0% | 4,134 | +33.4% | 0.00% | 0.0% |
| Q1 2019 | $251,000 | +4.1% | 3,098 | -33.6% | 0.00% | 0.0% |
| Q3 2018 | $241,000 | – | 4,669 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |